Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-Label Trial of Veligrotug in Participants With Thyroid Eye Disease Who Previously Responded to TeprotumumabCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorderNot yet recruitingPhase 42026-09-21NCT07832136

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Viridian Therapeutics, Inc.4

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Baylor College of Medicine Alkek Eye CenterHoustonUnited States1
Kahana Oculoplastic & Orbital SurgeryLivoniaUnited States3
Neuro-Eye Clinical TrialsHoustonUnited States1
Office of Dr. Amy Patel Jain, MDNewport BeachUnited States1
Ophthalmic Consultants of BostonEast WeymouthUnited States3
Sarasota Retina InstituteSarasotaUnited States9
The Center for Eye and Facial Plastic SurgerySomersetUnited States1
University HealthKansas CityUnited States7